Clinical Trials
59 trialscruciall
Second Affiliated Hospital, School of Medicine, Zhejiang University
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
CAPT-HN
SWOG Cancer Research Network
SAVE-GEJ
Peking University People's Hospital
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
Fudan University
NIVO402025
Blokhin's Russian Cancer Research Center
Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
Zhejiang Provincial People's Hospital
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
PIPAC in Gastric Peritoneal Metastasis
Chinese University of Hong Kong
HVA-MPAL
Guangdong Second Provincial General Hospital
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
Sun Yat-sen University
NeoMARS
Peking University
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients
Abbisko Therapeutics Co, Ltd
ELPIS
Yonsei University
Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies
University of Vermont Medical Center
Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Peking University First Hospital
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
Huabo Biopharm Co., Ltd.
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
Henan Cancer Hospital
Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy
Instituto Oncoclinicas
Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
DZ-002-201
Hoag Memorial Hospital Presbyterian
A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment
Regeneron Pharmaceuticals
HORIZON
Mayo Clinic
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
Peking University
TRANSFORM-GBC
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression
Tomsk National Research Medical Center of the Russian Academy of Sciences
Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107
Tomsk National Research Medical Center of the Russian Academy of Sciences
Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Tau PET Outcomes With Anti-amyloid Immunotherapies
Mayo Clinic
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Taiho Oncology, Inc.
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
MeiraGTx UK II Ltd
Patients With High-grade Pancreatic Neuroendocrine Tumors
National Cancer Center, Korea
SAFIR3LibHERty
UNICANCER
Personalized SBRT in Early-Stage Peripheral NSCLC
Tianjin Medical University Cancer Institute and Hospital
Sonodynamic-Chemoradiotherapy Integration in Glioblastoma
The First Affiliated Hospital of Zhengzhou University
68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
Peking Union Medical College Hospital
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Autolus Limited
IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma
The First Affiliated Hospital of Xiamen University
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
The First Affiliated Hospital of Zhengzhou University
GUIDANCE
University of Cologne
GALENT-BT
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
SAFE
Taipei City Hospital
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Pediatric Transplantation & Cellular Therapy Consortium
EXCEL
Pediatric Transplantation & Cellular Therapy Consortium
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
St. Petersburg State Pavlov Medical University
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
ECCO
Chongqing University Cancer Hospital
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia
National Institute of Pediatrics, Mexico
CISART
Fujian Medical University Union Hospital
Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University